Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SAI Life Sciences (SAILS12 IN)
Watchlist
32
Analysis
Health Care
•
India
SAI Life Sciences Limited develops pharmaceuticals. The Company focuses on drug and active ingredient discovery, development, and manufacturing. SAI Life Sciences manages research facilities worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SAI Life Sciences
•
12 Dec 2024 15:25
Sai Life Sciences IPO - Quick Thoughts on Peer Comp and Valuation
Sai Life Sciences is looking to raise up to US$360m in its upcoming India IPO. In this note, we will undertake a quick peer comparison and talk...
Akshat Shah
Follow
552 Views
Share
bearish
•
International Gemological Institute
•
12 Dec 2024 13:56
IGI (India) IPO - Unique Exposure but Questionable Acquisition, and 4x Returns for PE in 18 Months
International Gemmological Institute (India) Limited (IGII) is looking to raise about US$500m in its upcoming India IPO. In this note, we look at...
Sumeet Singh
Follow
737 Views
Share
bullish
•
SAI Life Sciences
•
11 Dec 2024 11:05
Sai Life Sciences Pre-IPO - Portfolio Expansion and Increased Production Capacity to Drive Growth
Sai Life Sciences is looking to raise up to US$360m in its upcoming India IPO. In this note, we talk about the company’s historical performance.
Akshat Shah
Follow
427 Views
Share
bullish
•
SAI Life Sciences
•
10 Dec 2024 17:37
SAI Life Sciences IPO- Growing and Profitable Business; Aggressive Pricing Limits Upside Potential
SAI Life Sciences intends to raise INR9.5B via India IPO. The IPO proceeds will be used for debt repayment. Marquee clientele and diverse portfolio...
Tina Banerjee
Follow
667 Views
Share
bullish
•
ASICS Corp
•
29 Jul 2024 08:48
ECM Weekly (29th July 2024) - ASICS, Kokusai, Amer, Hyundai, Timee, Sanil, Akum, Bloks, Ola Electric
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
Sumeet Singh
Follow
600 Views
Share
First
Previous
3
4
5
6
7
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x